ABOUT COMP

COMP reflects the cartilage turnover in the joint

Cartilage Oligomeric Matrix Protein (COMP) leaks continously from the joint into the blood. In patients with Rheumatoid arthritis and/or Osteoarthritis a blood test can predict the risk of chronic joint disease at an early stage.
FOCUS LETTER 6

Recent data suggest the existence of different phenotypic subsets of RA at clinical onset and elevated serum COMP levels ​​should be interpreted in relation to this new approach

In recent years, data have been published to suggest that anti-CCP positive and anti-CCP negative RA constitute two different phenotypic manifestations of RA with respect to both clinical prognosis and underlying disease mechanisms.

For US Customers Please note that, in the US, COMP® ELISA is approved for Research Use Only. Not for use in diagnostic procedures.
© 2010, AnaMar AB, Kungsportsavenyn 22, SE-411 36, Göteborg, Sweden
Phone: +46 31 732 4140, Fax: +46 31 732 41 49, info@anamar.com